Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemox Chemotherapy”

Showing 4 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07679399
What this trial is testing

A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.

Who this might be right for
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital 222
Large-scale testing (Phase 3)WithdrawnNCT02534337
What this trial is testing

Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University
Testing effectiveness (Phase 2)Study completedNCT03092895
What this trial is testing

SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Who this might be right for
Advanced Primary Liver CancerAdvanced Biliary Tract Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 157
Testing effectiveness (Phase 2)Study completedNCT07304388
What this trial is testing

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-sen University 96

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation